“Car-T and Bispecific Antibodies for Refractory Non-Hodgkin Lymphoma: Long-Term Safety and Autoimmune Sequelae”. Journal of Carcinogenesis 24, no. 6s (September 24, 2025): 805–820. Accessed January 15, 2026. https://carcinogenesis.com/index.php/JOC/article/view/1781.